Nanomedicinal delivery of stimulator of interferon genes agonists: Recent advances in virus vaccination

Saborni Chattopadhyay, Che Ming Jack Hu

研究成果: Review article同行評審

2 引文 斯高帕斯(Scopus)

摘要

The discovery of stimulator of interferon genes (STING) and their agonists as primary components that link antiviral innate and adaptive immunity has motivated growing research on STING agonist-mediated immunotherapy and vaccine development. To overcome the delivery challenge in shuttling highly polar STING agonists, typically in the form of cyclic dinucleotides, to target cells and to STING proteins in cellular cytosol, numerous nanoformulation strategies have been implemented for effective STING activation. While many STING-activating nanoparticles are developed to enhance anticancer immunotherapy, their adoption as vaccine adjuvant has vastly propelled antiviral vaccination efforts against challenging public health threats, including HIV, influenza and coronaviruses. In light of the COVID-19 pandemic that has thrusted vaccine development into the public spotlight, this review highlights advances in nanomedicinal STING agonist delivery with an emphasis on their applications in antiviral vaccination.

原文English
頁(從 - 到)2883-2894
頁數12
期刊Nanomedicine
15
發行號29
DOIs
出版狀態Published - 2020 十二月

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Materials Science(all)

指紋 深入研究「Nanomedicinal delivery of stimulator of interferon genes agonists: Recent advances in virus vaccination」主題。共同形成了獨特的指紋。

引用此